Healthcare Triangle

HCTI

Market cap $3.31M

Names Veteran Health Tech & AI Services Leader Sumit Ganguli as Chairman & CEO to Fuel Multi-Year Recurring Revenue Growth Across a Multi-Billion-Dollar Healthcare AI Market PLEASANTON, Calif., July 27, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (NASDAQ: HCTI), a healthcare and life sciences technology company enabling digital transformation through cloud, data, artificial intelligence, and security solutions, today announced that proven industry executive Sumit Ganguli has been appointed Chairman and Chief Executive Officer of Purpose Health, Inc., HCTI's wholly owned, AI-led healthcare technology services subsidiary.

JERSEY CITY, N.J., June 12, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announces the closing of Healthcare Triangle, Inc. (Nasdaq: HCTI) private placement of 15% original issue discount senior convertible promissory notes in the aggregate principal amount of $4.235 Million for aggregate gross proceeds of approximately $3.6 million, before deducting placement agent fees and other offering expenses.

PLEASANTON, Calif., June 12, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announces the closing of a private placement of its 15% original issue discount senior convertible promissory notes in the aggregate principal amount of $4.235 million for aggregate gross proceeds of approximately $3.6 million, before deducting placement agent fees and other related offering expenses.

Recent Acquisitions powers the Revenue Growth and Gross Profit PLEASANTON, Calif., May 14, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today reported financial results for the first quarter ended March 31, 2026.

Positioning this new platform at the intersection of AI, healthcare delivery, and preventive wellness for Its Global Healthcare Expansion Strategy PLEASANTON, Calif., April 23, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced the launch of ZoraNex , an AI-driven digital self-care therapy platform developed under its wholly owned subsidiary, QuantumNexis Inc ("QuantumNexis").

Middle East and North Africa (MENA) market to is projected to expand to $412 billion by 2032. and the HCTI vision is to be part of the growth with several Healthcare Customer wins by its subsidiary QuantumNexis in Africa PLEASANTON, Calif.

Agentic AI market is projected to expand to $200 Billion by 2034 and HCTI vision is to be part of that growth PLEASANTON, Calif., March 25, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced its deployment of Agentic AI to Teyame.AI's Customer Engagement Platform.

PLEASANTON, Calif., March 11, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries, today announces that its Board of Directors has approved a share repurchase program authorizing the Company to repurchase up to $2,000,000 of its outstanding common stock ("2026 Share Repurchase Plan").

The Dubai Operation strengthens Healthcare Triangle's mission to accelerate TeleHelath, Digital Therapeutics and population-scale care delivery across GCC. PLEASANTON, Calif.

PLEASANTON, Calif., Feb. 26, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced today that it has entered into definitive agreements for the purchase and sale of 681,553 shares of common stock (or prefunded warrants in lieu thereof), par value $0.00001 per share, at a purchase price of $5.81 per share in a registered direct offering priced at-the-market under Nasdaq rules.